Chronic administration of alachlor in the diet at a level of 126 mg/kg/day has previously been shown to cause an increase in benign thyroid follicular cell tumors in male Long-Evans rats. Studies were conducted to elucidate the mechanism of the alachlor-induced thyroid tumors in the male rat by evaluating changes in parameters that are collectively associated with a hormonally mediated mode of action for thyroid neoplasia. Male Long-Evans rats were administered 126 mg alachlor/kg body wt/day via the diet for up to 120 days. One group of animals was removed from alachlor-treated diet after 60 days and received untreated diet for an additional 60 days. Liver and thyroid weights and serum levels of triiodothyronine (T 3 ), thyroxine (T 4 ), and thyroid-stimulating hormone (TSH), as well as hepatic uridine diphosphate glucuronosyl transferase (UDPGT) activity, were determined at 7, 14, 28, 60, and 120 days of treatment. Liver and thyroid weights, hepatic UDPGT activity, and circulating levels of TSH were significantly increased in animals administered alachlor. These increases were seen as early as 7 days after alachlor administration. Circulating levels of T 4 in alachlor-treated animals were significantly decreased compared with controls at 7 days, but had returned to control levels by 60 days. T 3 levels were elevated at all time points except at 28 days. The changes in TSH and T 3 levels, hepatic UDPGT activity, and liver weights were all reversible on elimination of alachlor from the diet. Thyroid weights did not completely return to control levels after removal of alachlor from the diet, although some recovery was evident. The results of this study clearly suggest that alachlor-induced thyroid neoplasia, observed in previous chronic bioassays with alachlor, was associated with increases in circulating TSH levels. Increased metabolism of T 4 via hepatic enzymatic conjugation (i.e., T 4 -UDPGT) appeared to be responsible for the increased TSH levels. These 1 Portions of these data were presented at the 1993 Society of Toxicology Annual Meeting in New Orleans.
effects were shown to be reversible on cessation of exposure to alachlor. In summary, evidence is presented for a hormonally mediated process for the development of thyroid follicular cell tumors.
C 1996 Socltty of Toxicology
Alachlor was developed by Monsanto Company and introduced in 1969 for the pre-emergence control of a broad spectrum of grass, sedge, and broadleaf weeds in corn, soybeans, dry beans, cotton, grain sorghum, sunflowers, peanuts, and other crops. Alachlor is the active ingredient in LASSO herbicide and is a member of the chloroacetanilide chemical family.
The oncogenic potential of alachlor has been assessed in a series of rodent chronic bioassays. These studies have demonstrated that administration of aJachJor for 24 months in the diet at 126 mg/kg/day, but not at 42 mg/kg/day or lower, results in the formation of benign tumors in the thyroid follicular cells of male rats. In addition, thyroid tumors were not observed at comparable doses in female rats or in mice of either sex (Stout el ai, 1983 (Stout el ai, , 1984 Daly and Hogan, 1981) . The highest dose level of 126 mg/kg/day was not well tolerated, based on excessive body weight loss (>30%), hepatocellular necrosis, and slightly decreased survival, all of which support the view that 126 mg/kg/day exceeded the MTD. A recovery group that received 126 mg/kg/day of alachlor for 6 months followed by untreated diet for 19 months showed no increase in thyroid tumors (Stout el ai, 1984) .
It is well established that chronic exposure of the rat thyroid gland to sustained elevated levels of thyroid-stimulating hormone (TSH) can result in the formation of thyroid gland hyperplasia and neoplasia (Furth, 1968 ). An increase in TSH levels can result from a reduction in levels of circulating thyroid hormones [triiodothyronine (T 3 ) and thyroxine (T 4 )] through release of negative feedback control of the pituitary gland (Sawin, 1969; Lissitsky, 1976) . In humans there is strong evidence that prolonged stimulation of thyroid follicular cells by increased TSH levels is not associated with an increased development of thyroid cancer (Curran and DeGroot, 1991) .
The study reported here (Hotz et ai, 1993; Brewster et ai, 1993) has evaluated the indirect hormonal mode of action of alachlor-induced thyroid follicularcell tumors by studying the effect of alachlor on a number of endpoints that are indicators of hypothalamic-pituitary-thyroid homeostasis.
MATERIALS AND METHODS
Animals and animal husbandry. Male Long-Evans rats [Crl: (LE)BR] were purchased from Charles River Breeding Laboratories, Inc. (Portage, MI). Animals were acclimated for a total of 15 to 20 days before being placed on study. The animals were housed individually in stainless-steel suspension cages in an environmentally controlled animal room (temperature, 64.4-78.8T; humidity, 40-70%) on a 12-hr light/12-hr dark cycle. Purina Certified Rodent Chow (No. 5002, Purina Mills, St. Louis, MO) and tap water were provided ad libitum. Twelve-week-old rats were randomly assigned to study groups based on body weight. Food consumption and animal body weights were determined weekly during the study. Animals were not fasted prior to sacrifice.
Materials.
The test material for this study was technical-grade alachlor (purity 94.6%) which was obtained from the manufacturing facility. All other chemicals were of the highest quality available and were purchased from Sigma Chemical Company (St. Louis, MO) or Fisher Scientific Products (Pittsburgh, PA) unless otherwise specified.
Diet preparation and analysis. Alachlor diets were prepared weekly by melting alachlor (mp = 41°C) into a liquid state and thoroughly mixing with Purina Certified Rodent Chow using a Hobart HCM-450 high-speed mixer (Troy, OH). The dietary concentration of alachlor provided a dose of 126 mg/kg body wt/day and was determined based on the average food consumption and animal body weights from the previous week. Analysis for test material homogeneity and dietary concentrations were determined by gas chromatographic (GC) analysis. Briefly, aliquots of 5 g of the dietary admixtures were shaken for 60 min in a total volume of 100 ml hexane. Six to eight milliliters of the extracted supemate was centrifuged at 1800 rpm (IEC, Model HN-SII) for 20 min. Two-microliter samples were injected into a gas chromatograph fitted with a nitrogen phosphorus detector using a fused silica, 25 m X 0.53 mm i.d. column packed with OV-1701 (J & W Scientific, Folsom, CA). The temperature of the column was set at 170°C for 12 min followed by a temperature program of 30°C/min to 220°C which was held for 2 min. The concentration of alachlor was integrated from the area of the generated peak.
Experimental outline. Five groups of animals were administered alachlor-treated diet at a dose level of 126 mg/kg/day for 7, 14, 28, 60, and 120 days (14 or 20 animals/dose level). Control animals received untreated diet. Twenty animals were maintained on alachlor-treated diet for 60 days, then returned to untreated diet for an additional 60 days to provide an indication of reversibility (Table 1) Euthanasia procedures.
At euthanasia, the rats were initially anesthetized with CO 2 .O 2 (80%:20%) Anesthesia was maintained with CO 2 :O 2 (60%:40%) and blood was collected via cardiac puncture or from the posterior vena cava. All collections were made between 7 am and 12 noon and alternated between control and treated animals since TSH exhibits diurnal variation (Singh et ai, 1967; Fukuda et ai, 1975) . Blood was collected into tubes and was allowed to stand at room temperature for approximately 1 hr. Serum was isolated by centrifugation at 2800 rpm for 15 min and stored frozen at approximately -70°C. Serum samples were shipped on dry ice to Am Lytics, Inc. (Gaithersburg, MD) for the determination of T 3 , T 4 , and TSH by radioimmunoassay (RIA). Levels of T 3 and T 4 were determined * Animals received alachlor-treated diet for 60 days followed by untreated diet for 60 days.
using commercially available RIA kits (Diagnostic Products, Los Angeles, CA). Reagents obtained from the National Pituitary Hormones and Antisera Reference Center (University of California, Los Angeles) were used in determining TSH concentrations by RIA (personal communication).
TSH activity is controlled in part by epinephrine levels through the hypothalamic-pituitary axis. Therefore it was critically important to minimize stress to the animals at the time of blood collection. Noise, light, and cage movement are known to markedly affect serum levels of TSH (Dohler et al, 1979) . Special precautions were taken in this study to minimize these exogenous factors and included maintenance of a silent animal room, gentle animal handling, and stratified collections early in the day.
Thyroid gland weight may be one of the most sensitive parameters in response to xenobiotic disturbances of the thyroid-pituitary feedback system (C. Capen. R. M. McClain, personal communications); therefore, special procedures for accurate weighing of thyroid glands were used for this study. At euthanasia, a section of the trachea with the thyroid glands attached was removed and fixed in 10% neutral buffered formalin for 48 to 72 hours After fixation, the thyroid glands along with the thyroid isthmus were isolated, cleared of fat and connective tissue, blotted and weighed.
At euthanasia, livers were also removed, rinsed in saline, blotted, and weighed. Livers used for T 4 -uridine diphosphate glucuronosyl transferase (UDPGT) analysis were stored frozen at approximately -70°C Microsomes were either prepared prior to the day of assay and stored frozen or prepared on the day of the assay and used immediately.
Thyroid gland histopathology. The thyroid glands were fixed in 10% neutral buffered formalin, processed, embedded in paraffin, sectioned at approximately 5 fim, and stained with hematoxylin and eosin. The thyroid glands were evaluated histologically without knowledge of the treatment group from which they were taken.
T 4 -UDPGT assay. Hepatic microsomes from frozen livers were prepared according to a modified method of Dent et al. (1976) . Briefly, a homogenate of liver with cold 20 HIM Tris/I.15% KCI buffer (1:4) was prepared using a Teflon glass homogenizer. The homogenate was centrifuged at 10,000g for 20 min at 4°C. The resulting supernatant was centrifuged at 4°C for 1 hr at 100,000g. The microsomal pellet was resuspended in 0.25 M sucrose-5.4 mM EDTA-20 mM Tris buffer (pH 7.4) to a final volume of I g of liver/ml of buffer and stored frozen at approximately -70°C until assayed or were used immediately. Protein concentration was determined using the dye binding method of Bradford (1976 McClain et al (1989) with the following modifications: microsomes (0.2 mg microsomal protein/ml) were incubated for 60 mm at 37°C in 66 IHM Tris-HCI buffer (pH 7.8) along with 10 IHM MgCl 2 , 2.5 mM UDPNAG (uridine 5'-diphospho-/V-acetylglucosamine), I fiM thyroxine, and | I25 I]T 4 (5 /zl/ml buffer-substrate). The reaction was started by the addition of 25 pel UDPGA (from a 40 mM stock). Blanks were prepared by adding UDPGA to the reaction mixtures after the reaction was stopped. Activity was expressed as pmol/min/mg protein and as pmol/ minAotal liver wt.
Statistical analysis.
Results were calculated as the means ± standard errors of the mean (SEM) for the number of animals indicated. Comparisons between control and treated animals were made with Dunnett's test (p =£ 0.05, two-sided) after ANOVA (Snedecor and Cochran. 1978, Steel and Tome, 1980) , unless indicated otherwise Fisher's exact test (p * 0.05 or p * 0.01) was used to compare microscopic findings of the thyroid glands (Fisher. 1950) . Outliers were eliminated using Grubbs 1 test (Grubbs. 1969: Grubbs and Beck, 1972) .
RESULTS

Clinical Observations, Body and Organ Weights
No abnormal clinical signs were observed in any animal on study and all animals survived the entire treatment period. There were no significant differences in terminal body weights between control and alachlor-treated animals. Liver weights were significantly increased in animals administered 126 mg alachlor/kg/day for 7, 14, 28, and 120 days (Table  2) . Liver weights returned to control levels in those animals that were exposed to alachlor-treated diet for 60 days and then maintained on control diet for 60 days. Thyroid weights significantly increased in animals administered alachlor in the diet for 14 days. This increase in thyroid weight was also observed at the later time points, except 28 days, when the increased weight was not statistically significant (Table  2) . Following the recovery period, thyroid weights had not completely returned to control levels in animals administered alachlor-treated diet for 60 days and then maintained on untreated diet for 60 days.
Serum TSH, T 4 , and T 3
Serum TSH concentrations were significantly increased in alachlor-treated rats 14, 28, and 60 days after exposure (Table 3 ). The maximal increase in TSH concentration was approximately 205% of control and was observed at 60 days on alachlor-treated diet. At 120 days, circulating levels of TSH were still increased 39% above control levels. Following 60 days on untreated diet, TSH returned to control levels.
Circulating levels of T 4 showed more temporal variation. T 4 levels were reduced 7 days after treatment (Table 3) and were increased approximately 35% above those of control rats at 14 days. Serum T 4 levels returned to control levels at the later time points.
The greatest increase in serum levels of T 3 occurred at 120 days (Table 3 ). The increase in T, levels was reversible following 60 days on control diet.
T 4 -Hepatic UDPGT Activity
Hepatic T 4 -UDPGT activity in animals administered alachlor for 14 and 28 days was significantly increased com- 
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Note. Values are means ± SEM of 14-20 animals/group/time point.° 60 days on alachlor diet followed by 60 days on untreated diet; compared with 120-day control animals for statistical analysis.
* Significantly different from control with Dunnett's test after ANOVA (p < 0.05). pared with control levels (approximately 168-194% of control, data not shown). When adjusted for liver weight and expressed as estimated total activity/liver weight, UDPGT activity was significantly higher than control values in animals maintained on alachlor diet for 28 and 60 days (Table  2 ). This trend of increased activity was also evident at 120 days, although it was not statistically significant. When animals were returned to untreated diet, the total UDPGT activity of animals previously exposed to alachlor was not significantly different from that of control animals.
Thyroid Gland Histopathology
A summary of the histological evaluation of the thyroid glands is presented in Table 4 . Exposure of rats to alachlor resulted in diffuse hypertrophic or focal hyperplastic changes in the follicular epithelium of the thyroid glands (Fig. 1) . There was the impression that diffuse hyperplastic changes occurred in the follicular epithelium of some animals with diffuse hypertrophic changes; however, the hyperplastic changes were subtle and could not be definitely established with qualitative evaluation. Microscopic changes were first apparent at low incidence on Day 14 and occurred at highest incidence on Day 28, with a gradual decline in incidence at Days 60 and 120. In addition to these changes, cystic hyperplasia of the follicular epithelium was also present at 60 and 120 days. There was still some evidence of follicular hypertrophy in several animals that had been exposed to alachlor for 60 days followed by a 60-day recovery period.
Data Summary
A summary of the effects of removal of alachlor from the diet on the parameters measured in this study is presented in Fig. 2 .
DISCUSSION
Continuous alachlor administration at a high dietary concentration resulted in elevated liver weights, UDPGT activity, serum TSH levels, and thyroid weights with microscopic changes in thyroid follicular cells. These changes occurred as early as 7 days after commencement of dietary administration of alachlor at 126 mg/kg body wt. Although changes in T 4 levels were variable with the length of time of alachlor administration, elevations in TSH were clearly evident. Considerable experimental evidence exists to indicate that changes in circulating levels of thyroid hormones plus morphological alterations in thyroid follicular cells are reversible when the cause of TSH elevation is removed (Hill et al., 1989) . In this study, elevated levels of TSH were reversible on removal of alachlor from the diet, as were liver weight and hepatic UDPGT activity. Thyroid weights showed a trend in returning to normal, although they were still slightly higher than in controls. The presence of residual hypertrophic or hyperplastic changes after the 60-day reversibility period is to be expected since a period of several months is often necessary to permit morphological changes to revert to normal after prolonged stimulation by TSH (Hill et al., 1989) . In rats, a chronic disturbance of the hypothalamic-pituitary-thyroid axis is often associated with the development of an increased incidence of thyroid follicular hyperplasia and neoplasia (Bielschowsky, 1955; Furth, 1968; Comer e; a/., 1985; Zbinden, 1988; McClain et al., 1988 McClain et al., , 1989 Hill et al., 1989; Semler et al., 1989; Thomas and Williams, 1991) . Long-term goitrogen administration to rats results in characteristic hyperplastic changes in thyroid follicular cells (Lemoine and Thurston, 1989) . Such disturbances may be brought about by a number of factors (i.e., iodine deficiency, partial thyroidectomy, or exposure to xenobiotics), all of which lead to a prolonged increase in circulating levels of TSH.
Hepatic microsomal enzymes play an important role in controlling thyroid hormone levels since glucuronidation is the rate-limiting step in the biliary elimination of T 4 , and sulfate conjugation is the rate-limiting step in the elimination of T 3 (McClain, 1989; Capen et al., 1991) . Continuous exposure of rats to a wide variety of chemicals may induce these hepatic enzymes and result in chronic stimulation of the thyroid by disrupting the hypothalamic-pituitary-thyroid axis, resulting in increased circulating levels of TSH. A wide range of xenobiotics that have been shown to induce liver microsomal enzymes also result in an increased incidence of thyroid tumors in rats. Most hepatic microsomal enzyme inducers, however, have no intrinsic carcinogenic activity and are not mutagenic or DNA reactive (Capen et al., 1991) . The current knowledge on the induction of thyroid follicular cell tumors in experimental animals strongly supports the view that tumor formation is governed by promotional mechanisms (Andrae and Greim, 1992) . The promotional effect on thyroid tumors is generally greater in rats than mice, and males are typically more sensitive than females. Thus, alachlor appears to act in a manner similar to that observed at Pennsylvania State University on March 1, 2013 http://toxsci.oxfordjournals.org/ Downloaded from for a wide range of chemicals that are inducers of hepatic drug-metabolizing enzymes. Consistent with this is the observation that alachlor is not mutagenic (Kier et al., 1995) , induces hepatic UDPGT, and produces thyroid tumors only at the high dose level in the male rat and not in female rats or mice of either sex. Alachlor has also demonstrated promotional activity in a liver initiation-promotion medium-term bioassay system (Akagi et al., 1992) .
The results of this study suggest that the elevated TSH levels associated with high-dose alachlor administration are responsible for the increased incidence of thyroid neoplasia. The increased levels of hepatic T 4 -UDPGT in alachlortreated rats did not result in persistently depressed circulating T 4 levels, most likely due to compensatory mechanisms. Other factors such as an altered ratio of total to free T 4 in the blood or decreased local conversion of T 4 to T 3 in the pituitary gland (Larsen, 1982; Shupnik et al., 1986; Hill et al., 1989) may explain how the variable changes with time seen in T 4 levels resulted in continuously elevated TSH levels. The consistently elevated serum T 3 values relative to controls may have been due to increased T 3 production resulting from elevated TSH levels with a normal T 3 excretion rate or due to increased peripheral deiodination of T 4 to T 3 (Schroeder-van-der Elst et al., 1990) .
Further, some degree of disruption of the hypothalamicpituitary-thyroid axis can be accommodated within the limits of the normal feedback mechanism without inducing hyperplasia of the thyroid follicular cells. Prolonged elevations in TSH in rats often result in an increased incidence of benign neoplasia, especially in male rats. This hormonemediated mechanism of carcinogenesis is considered to be a threshold phenomenon.
Understanding the mode of action by which a chemical induces thyroid neoplasia provides a more rational basis for extrapolating the findings from long-term rodent studies to the assessment of human risk. This and previous studies with alachlor suggest that the mode of action for alachlor-induced thyroid tumors in male rats involves threshold-based nongenotoxic mechanisms. This is particularly relevant for risk assessment since the hormonally mediated mode of action for thyroid neoplasia is not known to occur in humans.
